Received Jun 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| BCG | BCG (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
drug allergy; This Spontaneous report was received from Consumer or other non health professional and referred to a/an 40-year-old Female Adult patient. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On an unknown date, patient started therapy with BCG Vaccine POWDER AND SOLVENT FOR TRANSDERMAL USE 79852488:TKAUnknown Batch/Lot Number dose form was Powder for injection via Percutaneous. The patient started therapy with BCG Vaccine POWDER AND SOLVENT FOR TRANSDERMAL USE 79852488:TKA for the treatment of Prevention of Tuberculosis, On an unknown date, the patient experienced drug allergy (Allergy to vaccine). The Outcome of Allergy to vaccine was not provided. The action taken with BCG Vaccine POWDER AND SOLVENT FOR TRANSDERMAL USE 79852488:TKA regarding Allergy to vaccine was Not applicable with Not Applicable dechallenge and rechallenge results. The Consumer or other non health professional considered the event Allergy to vaccine (,) to be related to BCG Vaccine POWDER AND SOLVENT FOR TRANSDERMAL USE 79852488:TKA The Consumer or other non health professional considered the event Allergy to vaccine to be non-serious